29 results on '"Fung, Henry"'
Search Results
2. Gaps in CIBMTR Reporting of High Risk Abnormalities in Multiple Myeloma
3. Long-Term Follow-up of Outcomes with Ptcy Gvhd Prophylaxis in PBSC Transplant: Decreased Chronic Gvhd and Improved Non-Relapse Mortality.
4. Retrospective Study Assessing Outcomes of AYA Patients with Lymphoma Following Auto Stem Cell Transplant
5. A Comparative Analysis of Engraftment Outcomes for Recipients of Allogeneic Hematopoietic Stem Cell Transplants (allo HSCT) and Post-Transplant Cyclophosphamide (PTCy) Based on Ideal Body Weight (IBW) or Actual Body Weight (ABW) Dosing of CD34-Positive Stem Cells
6. Safety and Efficacy of Oral Vancomycin Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients
7. Importance of Monitoring Stem Cell Apheresis Efficiency
8. Day 30 and Day 100 CD3 Chimerism Levels Are Not Predictive of Progression Free Survival, Overall Survival and Gvhd Outcomes in Allogenic Stem Cell Transplants Using Post-Transplant Cyclophosphamide
9. Safety and Efficacy of Gvhd Prophylaxis with Abatacept and Reduced Dose Post-Transplant Cytoxan in Matched Unrelated and Matched Related Allogeneic Peripheral Stem Cell Transplants
10. Efficacy of Post-Transplant Cytoxan for Gvhd Prophylaxis in Mismatched Unrelated Allogeneic Stem Cell Transplant
11. Uniform Plerixafor Dosing for Patients Greater Than 83 Kg
12. Fox Chase-Temple University Hospital BMT Program Experience of New Database Development
13. Using Oral Vancomycin As Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients Is Associated with Increased Gram Negative Bacteremia
14. Retrospective Analysis of Efficacy and Toxicity of Melphalan 200mg/m2 and 140mg/m2 for Autologous Stem Cell Transplant in Multiple Myeloma
15. Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
16. One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients (Pts) with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)
17. Effects of Post-Transplant Cyclophosphamide on Early Donor Chimerism Outcomes after Allogeneic Stem Cell Transplant with Busulfan Based Myeloablative Conditioning
18. 418 - Day 30 and Day 100 CD3 Chimerism Levels Are Not Predictive of Progression Free Survival, Overall Survival and Gvhd Outcomes in Allogenic Stem Cell Transplants Using Post-Transplant Cyclophosphamide
19. 342 - Safety and Efficacy of Gvhd Prophylaxis with Abatacept and Reduced Dose Post-Transplant Cytoxan in Matched Unrelated and Matched Related Allogeneic Peripheral Stem Cell Transplants
20. 142 - Safety and Efficacy of Oral Vancomycin Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients
21. 87 - Importance of Monitoring Stem Cell Apheresis Efficiency
22. 606 - Uniform Plerixafor Dosing for Patients Greater Than 83 Kg
23. 594 - Fox Chase-Temple University Hospital BMT Program Experience of New Database Development
24. 329 - Efficacy of Post-Transplant Cytoxan for Gvhd Prophylaxis in Mismatched Unrelated Allogeneic Stem Cell Transplant
25. 500 - Retrospective Analysis of Efficacy and Toxicity of Melphalan 200mg/m2 and 140mg/m2 for Autologous Stem Cell Transplant in Multiple Myeloma
26. 414 - One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients (Pts) with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)
27. 251 - Effects of Post-Transplant Cyclophosphamide on Early Donor Chimerism Outcomes after Allogeneic Stem Cell Transplant with Busulfan Based Myeloablative Conditioning
28. 69 - Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
29. Safety and Efficacy of Oral Vancomycin Prophylaxis Against Clostridioides DifficileInfection in Stem Cell Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.